[Renal cell carcinoma associated proteins. Isolation, cloning and immunogenicity evaluation]
- PMID: 17628779
- DOI: 10.1007/s00120-007-1418-2
[Renal cell carcinoma associated proteins. Isolation, cloning and immunogenicity evaluation]
Similar articles
-
Enhance the anti-renca carcinoma effect of a DNA vaccine targeting G250 gene by co-expression with cytotoxic T-lymphocyte associated antigen-4(CTLA-4).Biomed Pharmacother. 2017 Jun;90:147-152. doi: 10.1016/j.biopha.2017.03.015. Epub 2017 Mar 26. Biomed Pharmacother. 2017. PMID: 28351777
-
HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.Int J Cancer. 2000 Aug 1;87(3):349-59. Int J Cancer. 2000. PMID: 10897039
-
Antigenic targets for renal cell carcinoma immunotherapy.Expert Opin Biol Ther. 2004 Nov;4(11):1791-801. doi: 10.1517/14712598.4.11.1791. Expert Opin Biol Ther. 2004. PMID: 15500407 Review.
-
Concomitant tumor and autoantigen vaccination supports renal cell carcinoma rejection.J Immunol. 2010 Jul 15;185(2):902-16. doi: 10.4049/jimmunol.0902683. Epub 2010 Jun 14. J Immunol. 2010. PMID: 20548033
-
Vaccines for colorectal cancer and renal cell carcinoma.Cancer J. 2011 Sep-Oct;17(5):283-93. doi: 10.1097/PPO.0b013e318232ff44. Cancer J. 2011. PMID: 21952277 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical